Cargando…

Hodgkin Lymphoma—The Spectrum from Diagnostics to Molecular Science, Movement and Current Treatment Approaches

Detalles Bibliográficos
Autor principal:	Hartmann, Sylvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216631/ https://www.ncbi.nlm.nih.gov/pubmed/37345063 http://dx.doi.org/10.3390/cancers15102726

Ejemplares similares

Current approaches to the treatment of non-Hodgkin's lymphoma
por: Gisselbrecht, Christian
Publicado: (2011)

Advances in the treatment of Hodgkin lymphoma: Current and future approaches
por: Ullah, Fauzia, et al.
Publicado: (2023)

P043: Molecular pathogenesis of Hodgkin lymphoma
por: Beeck, Lilian, et al.
Publicado: (2022)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas
por: Pytlik, Robert, et al.
Publicado: (2020)

Immunotherapies in Non-Hodgkin’s Lymphoma
por: Bezombes, Christine, et al.
Publicado: (2021)

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas
por: Poggio, Teresa, et al.
Publicado: (2018)

Current directions in the treatment of classical Hodgkin lymphoma
por: Keller, Frank G., et al.
Publicado: (2023)

Current advances in Hodgkin’s lymphoma
por: Vadakara, Joseph, et al.
Publicado: (2019)

Maintaining Efficacy But Decreasing Toxicity in the Treatment of Hodgkin Lymphoma
por: Ansell, Stephen M.
Publicado: (2017)

Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma
por: van Bladel, Diede A. G., et al.
Publicado: (2022)

Primary splenic lymphoma: Current diagnostic trends
por: Ingle, Sachin B, et al.
Publicado: (2016)

Second cancer risk following Hodgkin lymphoma
por: Sud, Amit, et al.
Publicado: (2017)

Basal autophagy is pivotal for Hodgkin and Reed-Sternberg cells' survival and growth revealing a new strategy for Hodgkin lymphoma treatment
por: Birkenmeier, Katrin, et al.
Publicado: (2016)

Hodgkin Lymphoma—Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients
por: Momotow, Jesko, et al.
Publicado: (2021)

PET-guided treatment in advanced-stage Hodgkin lymphoma: yes but which one?
por: Rossi, Cédric, et al.
Publicado: (2019)

T‐cell‐derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
por: Bein, Julia, et al.
Publicado: (2022)

Molecular biology of Hodgkin lymphoma
por: Weniger, Marc A., et al.
Publicado: (2021)

The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology
por: Hartmann, Sylvia, et al.
Publicado: (2023)

Managing advanced stage Hodgkin lymphoma
por: Saikia, TK
Publicado: (2015)

Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma
por: Kurtz, David M.
Publicado: (2021)

Spectrum of common Hodgkin lymphoma and non-Hodgkin lymphomas subtypes in Zambia: a 3-year records review
por: Polepole, Pascal, et al.
Publicado: (2021)

Management of classical Hodgkin lymphoma: a look at up to date evidence and current treatment approaches
por: Hanel, Walter, et al.
Publicado: (2022)

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?
por: Hartmann, Sylvia, et al.
Publicado: (2013)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Hodgkin Lymphoma: Biology and Differential Diagnostic Problem
por: Takahara, Taishi, et al.
Publicado: (2022)

Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
por: Hartmann, Sylvia, et al.
Publicado: (2021)

Progress in understanding the biology of nodular lymphocyte-predominant Hodgkin lymphoma
por: Straus, David J.
Publicado: (2021)

Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies
por: Paviglianiti, Annalisa, et al.
Publicado: (2023)

Expanding the bacterial origins of nodular lymphocyte-predominant Hodgkin lymphoma
por: Gandhi, Maher K., et al.
Publicado: (2023)

The molecular mechanisms of classic Hodgkin's lymphoma.
por: Felberbaum, Rachael S.
Publicado: (2005)

Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma
por: Jezeršek Novaković, Barbara, et al.
Publicado: (2021)

Sports Medicine and Movement Sciences
por: Musumeci, Giuseppe
Publicado: (2022)

Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology
por: Hartmann, Sylvia, et al.
Publicado: (2014)

Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma
por: Eberth, Sonja, et al.
Publicado: (2010)

The riddle of lymphoma BCR-antigenes
por: Thurner, Lorenz, et al.
Publicado: (2018)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
por: Biasoli, Irene, et al.
Publicado: (2023)

Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
por: Goncharova, Olga, et al.
Publicado: (2019)

A Diagnostic Surprise: Primary Hodgkin’s Lymphoma of the Lung
por: Sinha, Ankur, et al.
Publicado: (2017)

Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma
por: Casagrande, Naike, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ek06us9p1qsvj0atfolqlt37dp